Applied Clinical Research, Clinical Trials and Regulatory Affairs

Genotoxic Impurities in Ranitidine Containing Products: An Overview

Pp: 155-161

Author(s): Shailesh Bhosale, Kamal Kant, Divya Goyal and Anoop Kumar*

DOI: 10.2174/2213476X07666200423081738

A Comprehensive Review of Regulatory Requirements and Registration Process of Pharmaceutical Drug Products in CIS Countries

Pp: 162-176

Author(s): Kapil Pihwal*, Neelam Pawar, Sheikh Aamir, Mohammad Shahbaz Alam and Vikas Rathee

DOI: 10.2174/2213476X07666200708105237

Safety and Quality of Nutraceuticals: Have FSSAI Guidelines been Able to Blaze the Trail?

Pp: 177-196

Author(s): Payal Dande*, Purva Samant, Yashita Singh and Umang Sheth

DOI: 10.2174/2213476X07666200825193259

Raw Data Management and Data Integrity in Pharmaceutical Product Development

Pp: 197-205

Author(s): Jenish Parmar, Priti Mehta*, Rajvi Patel, Manan Shah and Charmy Kothari

DOI: 10.2174/2213476X07999200901110354

Self-Emulsifying Drug Delivery System (SEDDS) and its Pharmaceutical Applications

Pp: 206-224

Author(s): Sankha Bhattacharya*

DOI: 10.2174/2213476X07666200827102951

Nanotechnology: Regulatory Outlook on Nanomaterials and Nanomedicines in United States, Europe and India

Pp: 225-236

Author(s): Rashi Malik* and Sharvil Patil*

DOI: 10.2174/2213476X06666191129094236

EU IVDR Regulatory Changes: An Overview of Requirements in (EU) 2017/746

Pp: 237-243

Author(s): Shashank Nayak*, M.P. Venkatesh and Pramod Kumar T.M

DOI: 10.2174/2213476X07666200327143023

Comparison of Maternal and Neonatal Outcomes in Case of Primary Cesarean Section Done During Late vs. Early Labor

Pp: 244-253

Author(s): Heena Anuff, Zeinah Rahman, Rajani Dube* and Shatha Taher Salman Al-Zuheiri

DOI: 10.2174/2213476X07666200708110738

Acknowledgements to Reviewers

Pp: 254-254

DOI: 10.2174/2213476X0703201125090232